MedTrace Logo

Endurant Stent Graft Natural Selection Global Postmarket Registry

NCT00870051 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1266

Last updated 2022-02-09

No results posted yet for this study

Summary

The purpose of ENGAGE is to prospectively collect global 'real world' data on the Endurant Stent Graft System from AAA subjects.

Conditions

  • Aortic Aneurysm, Abdominal

Interventions

DEVICE

Endurant Stent Graft

Endurant Stent Graft implantation

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Vicente Riambau, Prof. · Hospital Clinic of Barcelona

  • Furuzan Numan, prof · Memorial Hospital Istanbul

  • Robert A. Fitridge, Dr. · The Queen Elizabeth Hospital, Woodville, South Adelaide, Australia

  • Yehuda Wolf, Prof. · Tel Aviv Sourasky Medical Center, Israel

  • Dittmar Böckler, Prof. · Universtiy of Heidelberg, Germany

  • Paul Hayes, Dr. · Addenbrookes Hospital, Cambridge, Great Britain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-08
Primary Completion
2021-09-23
Completion
2021-09-23

Countries

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Canada
  • China
  • Colombia
  • Czechia
  • France
  • Germany
  • Greece
  • Hong Kong
  • Israel
  • Italy
  • Lithuania
  • Netherlands
  • New Zealand
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • Turkey (Türkiye)
  • United Kingdom
  • Uruguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00870051 on ClinicalTrials.gov